Chinese General Practice ›› 2022, Vol. 25 ›› Issue (27): 3384-3389.DOI: 10.12114/j.issn.1007-9572.2022.0269
• Article • Previous Articles Next Articles
Received:
2022-03-05
Revised:
2022-05-10
Published:
2022-09-20
Online:
2022-06-23
Contact:
Zhen YU
About author:
通讯作者:
玉珍
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0269
组别 | 例数 | 胎龄( | 出生体质量( | 入院出生时间〔M(Q1,Q3),h〕 | SGA〔n( %)〕 | RDS 3~4级〔n( %)〕 | 生后Apgar评分〔M(Q1,Q3),分〕 | ||
---|---|---|---|---|---|---|---|---|---|
1 min | 5 min | 10 min | |||||||
INSURE组 | 122 | 32(30,33) | 1 505.1±384.8 | 0.5(0.5,1.0) | 55(45.1) | 24(19.7) | 9(7,10) | 10(9,10) | 10(9,10) |
MV组 | 61 | 30(29,32) | 1 342.4±523.9 | 0.5(0.5,1.0) | 26(42.6) | 10(16.4) | 6(3,9) | 8(6,10) | 9(7,10) |
检验统计量值 | -2.926b | 2.152b | -1.463 | 0.100a | 0.289a | -3.888 | -4.575 | -3.913 | |
P值 | 0.003 | 0.034 | 0.143 | 0.752 | 0.591 | <0.001 | <0.001 | <0.001 | |
组别 | 胎位异常〔n(%)〕 | 脐带异常〔n(%)〕 | 胎心异常〔n(%)〕 | 胎盘异常〔n(%)〕 | 羊水污染〔n(%)〕 | 宫内窘迫〔n(%)〕 | 母亲年龄( | 母亲长期居住地海拔高度〔M(Q1,Q3),m〕 | 母亲产检次数〔M(Q1,Q3),次〕 |
INSURE组 | 8(6.6) | 16(13.1) | 21(17.2) | 17(13.9) | 14(11.5) | 29(23.8) | 29.8±5.8 | 3 903.0(3 651.0,4 300.0) | 5(4,7) |
MV组 | 6(9.8) | 9(14.8) | 10(16.4) | 5(8.2) | 13(21.3) | 12(19.7) | 30.3±5.6 | 3 800.0(3 651.0,4 150.0) | 5(4,7) |
检验统计量值 | 0.619a | 0.093a | 0.019a | 1.266a | 3.128a | 0.393a | 0.517b | -1.525 | -0.131 |
P值 | 0.432 | 0.761 | 0.889 | 0.261 | 0.077 | 0.531 | 0.606 | 0.127 | 0.896 |
组别 | 母亲剖宫产率〔n(%)〕 | 母亲异常分娩率〔n(%)〕 | 母亲为农牧民〔n(%)〕 | 母亲产前糖皮质激素治疗〔n(%)〕 | 母亲不良孕产史〔n(%)〕 | 母亲ICP〔n(%)〕 | 母亲胎膜早破〔n(%)〕 | 母亲妊娠期高血压〔n(%)〕 | 母亲产前感染〔n(%)〕 |
INSURE组 | 70(57.4) | 9(7.4) | 63(51.6) | 7(5.7) | 42(34.4) | 11(9.1) | 16(13.1) | 63(51.6) | 5(4.1) |
MV组 | 33(54.1) | 2(3.3) | 37(60.7) | 10(16.4) | 23(37.7) | 7(11.5) | 13(21.3) | 28(45.9) | 2(3.3) |
检验统计量值 | 0.178a | 0.592a | 1.334a | 5.480a | 0.191a | 0.277a | 2.049a | 0.536a | 0.074c |
P值 | 0.673 | 0.441 | 0.248 | 0.019 | 0.662 | 0.598 | 0.152 | 0.464 | 1.000 |
Table 1 Comparison of clinical data of two groups of RDS premature infants
组别 | 例数 | 胎龄( | 出生体质量( | 入院出生时间〔M(Q1,Q3),h〕 | SGA〔n( %)〕 | RDS 3~4级〔n( %)〕 | 生后Apgar评分〔M(Q1,Q3),分〕 | ||
---|---|---|---|---|---|---|---|---|---|
1 min | 5 min | 10 min | |||||||
INSURE组 | 122 | 32(30,33) | 1 505.1±384.8 | 0.5(0.5,1.0) | 55(45.1) | 24(19.7) | 9(7,10) | 10(9,10) | 10(9,10) |
MV组 | 61 | 30(29,32) | 1 342.4±523.9 | 0.5(0.5,1.0) | 26(42.6) | 10(16.4) | 6(3,9) | 8(6,10) | 9(7,10) |
检验统计量值 | -2.926b | 2.152b | -1.463 | 0.100a | 0.289a | -3.888 | -4.575 | -3.913 | |
P值 | 0.003 | 0.034 | 0.143 | 0.752 | 0.591 | <0.001 | <0.001 | <0.001 | |
组别 | 胎位异常〔n(%)〕 | 脐带异常〔n(%)〕 | 胎心异常〔n(%)〕 | 胎盘异常〔n(%)〕 | 羊水污染〔n(%)〕 | 宫内窘迫〔n(%)〕 | 母亲年龄( | 母亲长期居住地海拔高度〔M(Q1,Q3),m〕 | 母亲产检次数〔M(Q1,Q3),次〕 |
INSURE组 | 8(6.6) | 16(13.1) | 21(17.2) | 17(13.9) | 14(11.5) | 29(23.8) | 29.8±5.8 | 3 903.0(3 651.0,4 300.0) | 5(4,7) |
MV组 | 6(9.8) | 9(14.8) | 10(16.4) | 5(8.2) | 13(21.3) | 12(19.7) | 30.3±5.6 | 3 800.0(3 651.0,4 150.0) | 5(4,7) |
检验统计量值 | 0.619a | 0.093a | 0.019a | 1.266a | 3.128a | 0.393a | 0.517b | -1.525 | -0.131 |
P值 | 0.432 | 0.761 | 0.889 | 0.261 | 0.077 | 0.531 | 0.606 | 0.127 | 0.896 |
组别 | 母亲剖宫产率〔n(%)〕 | 母亲异常分娩率〔n(%)〕 | 母亲为农牧民〔n(%)〕 | 母亲产前糖皮质激素治疗〔n(%)〕 | 母亲不良孕产史〔n(%)〕 | 母亲ICP〔n(%)〕 | 母亲胎膜早破〔n(%)〕 | 母亲妊娠期高血压〔n(%)〕 | 母亲产前感染〔n(%)〕 |
INSURE组 | 70(57.4) | 9(7.4) | 63(51.6) | 7(5.7) | 42(34.4) | 11(9.1) | 16(13.1) | 63(51.6) | 5(4.1) |
MV组 | 33(54.1) | 2(3.3) | 37(60.7) | 10(16.4) | 23(37.7) | 7(11.5) | 13(21.3) | 28(45.9) | 2(3.3) |
检验统计量值 | 0.178a | 0.592a | 1.334a | 5.480a | 0.191a | 0.277a | 2.049a | 0.536a | 0.074c |
P值 | 0.673 | 0.441 | 0.248 | 0.019 | 0.662 | 0.598 | 0.152 | 0.464 | 1.000 |
组别 | 例数 | 不同胎龄 | ||
---|---|---|---|---|
<29周 | 29~32周 | 33~36+6周 | ||
INSURE组 | 122 | 8(6.6) | 74(60.7) | 40(32.8) |
MV组 | 61 | 13(21.3) | 35(57.4) | 13(21.3) |
χ2值 | 9.637 | |||
P值 | 0.008 |
Table 2 Comparison of the composition of premature infants of different gestational ages between two groups
组别 | 例数 | 不同胎龄 | ||
---|---|---|---|---|
<29周 | 29~32周 | 33~36+6周 | ||
INSURE组 | 122 | 8(6.6) | 74(60.7) | 40(32.8) |
MV组 | 61 | 13(21.3) | 35(57.4) | 13(21.3) |
χ2值 | 9.637 | |||
P值 | 0.008 |
组别 | 例数 | 5 min Apgar评分 | ||
---|---|---|---|---|
≤5分 | 6~7分 | 8~10分 | ||
INSURE组 | 122 | 1(0.8) | 9(7.4) | 112(91.8) |
MV组 | 61 | 9(3.3) | 10(16.4) | 42(68.9) |
χ2值 | 18.991 | |||
P值 | <0.001 |
Table 3 Comparison of the composition of premature infants of different 5 min Apgar score between two groups
组别 | 例数 | 5 min Apgar评分 | ||
---|---|---|---|---|
≤5分 | 6~7分 | 8~10分 | ||
INSURE组 | 122 | 1(0.8) | 9(7.4) | 112(91.8) |
MV组 | 61 | 9(3.3) | 10(16.4) | 42(68.9) |
χ2值 | 18.991 | |||
P值 | <0.001 |
组别 | 例数 | BPD〔n(%)〕 | 肺出血〔n(%)〕 | 气胸〔n(%)〕 | 颅内出血〔n(%)〕 | 第2剂PS〔n(%)〕 | 住院天数〔M(Q1,Q3),d〕 | 死亡〔n(%)〕 |
---|---|---|---|---|---|---|---|---|
INSURE组 | 122 | 18(14.8) | 8(6.6) | 6(4.9) | 23(18.9) | 1(0.8) | 27(15,42) | 10(8.2) |
MV组 | 61 | 16(26.2) | 15(24.6) | 4(6.6) | 7(11.5) | 3(4.9) | 31(4,46) | 24(39.3) |
χ2(Z)值 | 3.540 | 12.034 | 0.212 | 1.615 | 3.195 | -0.157a | 26.081 | |
P值 | 0.060 | 0.001 | 0.733 | 0.289 | 0.109 | 0.875 | <0.001 |
Table 4 Comparison of complications and outcomes between two groups of RDS premature infants
组别 | 例数 | BPD〔n(%)〕 | 肺出血〔n(%)〕 | 气胸〔n(%)〕 | 颅内出血〔n(%)〕 | 第2剂PS〔n(%)〕 | 住院天数〔M(Q1,Q3),d〕 | 死亡〔n(%)〕 |
---|---|---|---|---|---|---|---|---|
INSURE组 | 122 | 18(14.8) | 8(6.6) | 6(4.9) | 23(18.9) | 1(0.8) | 27(15,42) | 10(8.2) |
MV组 | 61 | 16(26.2) | 15(24.6) | 4(6.6) | 7(11.5) | 3(4.9) | 31(4,46) | 24(39.3) |
χ2(Z)值 | 3.540 | 12.034 | 0.212 | 1.615 | 3.195 | -0.157a | 26.081 | |
P值 | 0.060 | 0.001 | 0.733 | 0.289 | 0.109 | 0.875 | <0.001 |
因素 | B | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|
胎龄 | 0.253 | 4.211 | 1.288 | (1.011,1.641) | 0.040 |
出生体质量 | -0.001 | 0.001 | 0.999 | (0.998,1.001) | 0.315 |
生后1 min Apgar评分 | 0.019 | 0.028 | 1.019 | (0.815,1.275) | 0.867 |
生后5 min Apgar评分 | 0.771 | 8.579 | 2.162 | (1.291,3.622) | 0.003 |
生后10 min Apgar评分 | -0.330 | 1.519 | 0.719 | (0.426,1.215) | 0.218 |
母亲产前糖皮质激素治疗 | 1.869 | 9.682 | 6.482 | (1.997,21.039) | 0.002 |
Table 5 Multivariate Logistic regression analysis of influencing factors of different NRDS treatment schemes for premature infants
因素 | B | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|
胎龄 | 0.253 | 4.211 | 1.288 | (1.011,1.641) | 0.040 |
出生体质量 | -0.001 | 0.001 | 0.999 | (0.998,1.001) | 0.315 |
生后1 min Apgar评分 | 0.019 | 0.028 | 1.019 | (0.815,1.275) | 0.867 |
生后5 min Apgar评分 | 0.771 | 8.579 | 2.162 | (1.291,3.622) | 0.003 |
生后10 min Apgar评分 | -0.330 | 1.519 | 0.719 | (0.426,1.215) | 0.218 |
母亲产前糖皮质激素治疗 | 1.869 | 9.682 | 6.482 | (1.997,21.039) | 0.002 |
[1] |
|
[2] |
邵肖梅,叶鸿瑁,丘小汕. 实用新生儿学[M]. 第5版. 北京:人民卫生出版社,2019.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
赵捷,杨传忠. 超早产儿发生支气管肺发育不良的影响因素[J]. 中华围产医学杂志,2017,20(11):824-828. DOI:10.3760/cma.j.issn.1007-9408.2017.11.012.
|
[10] |
李帅军,冯琪,童笑梅,等. 超低出生体质量儿复苏及呼吸支持治疗的多中心临床研究[J]. 中华新生儿科杂志,2021,36(2):27-32. DOI:10.3760/cma.j.issn.2096-2932.2021.02.005.
|
[11] |
|
[12] |
|
[13] |
超未成熟儿与超低出生体质量儿研究协作组. 超未成熟儿与超低出生体质量儿产前糖皮质激素使用情况及其对预后影响的多中心调查[J]. 中华围产医学杂志,2020,23(5):302-310. DOI:10.3760/cma.j.cn113903-20190823-00512.
|
[14] |
江苏省NICU母乳喂养质量改进临床研究协作组. 江苏省13家医院极早产儿死亡危险因素分析[J]. 中华新生儿科杂志,2021,36(5):24-29. DOI:10.3760/cma.j.issn.2096-2932.2021.05.006.
|
[15] |
德穷,吴俣,张育彤,等. 西藏藏族孕产妇产前检查次数与低出生体质量儿的关联[J]. 中华疾病控制杂志,2019,23(11):1348-1352. DOI:10.16462/j.cnki.zhjbkz.2019.11.010.
|
[16] |
李才萍. 妊娠期高血压疾病患者终止妊娠时机及分娩方式临床研究[J]. 实用妇科内分泌电子杂志,2017,4(23):64-65. DOI:10.3969/j.issn.2095-8803.2017.23.043.
|
[17] |
|
[18] |
超未成熟儿与超低出生体质量儿研究协作组. 超未成熟儿与超低出生体质量儿临床救治结局分析[J]. 中华新生儿科杂志,2020,35(2):108-112. DOI:10.3760/cma.j.issn.2096-2932.2020.02.008.
|
[19] |
李天浩,林新祝. 早期呼吸支持技术对早产儿神经系统预后的影响[J]. 中华新生儿科杂志,2018,33(5):392-396. DOI:10.3760/cma.j.issn.2096-2932.2018.05.020.
|
[20] |
江苏省新生儿重症监护病房母乳质量改进临床研究协作组. 多中心回顾性分析极低及超低出生体质量儿支气管肺发育不良的临床特点及高危因素[J]. 中华儿科杂志,2019,57(1):33-39. DOI:10.3760/cma.j.issn.0578-1310.2019.01.009.
|
[21] |
董梦园,吉玲,刘萌萌,等. 呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J]. 中国儿童保健杂志,2021,29(6):685-688. DOI:10.11852/zgetbjzz2020-2150.
|
[22] |
庄严,高喜容,刘新晖,等. 超早产儿出院时临床结局及影响因素分析[J]. 中华新生儿科杂志,2017,32(2):86-90. DOI:10.3760/cma.j.issn.2096-2932.2017.02.003.
|
[1] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[2] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[3] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[4] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[5] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[6] | ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117. |
[7] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[8] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[9] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[10] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[11] | MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102. |
[12] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[13] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[14] | GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050. |
[15] | WANG Minghuan, LI Yuhong, YU Min, WANG Yougang, YU Qiaozhi, YANG Fangfang, YUAN Dehui, ZHANG Liu. Effect of Allostatic Load on Adverse Pregnancy Outcomes of Women in Late Pregnancy [J]. Chinese General Practice, 2023, 26(32): 4064-4069. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||